These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 26247733)
21. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT. Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128 [TBL] [Abstract][Full Text] [Related]
22. Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten. Barbieri I; Pensa S; Pannellini T; Quaglino E; Maritano D; Demaria M; Voster A; Turkson J; Cavallo F; Watson CJ; Provero P; Musiani P; Poli V Cancer Res; 2010 Mar; 70(6):2558-67. PubMed ID: 20215508 [TBL] [Abstract][Full Text] [Related]
23. Alcohol promotes mammary tumor development via the estrogen pathway in estrogen receptor alpha-negative HER2/neu mice. Wong AW; Dunlap SM; Holcomb VB; Nunez NP Alcohol Clin Exp Res; 2012 Apr; 36(4):577-87. PubMed ID: 21981381 [TBL] [Abstract][Full Text] [Related]
24. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis. Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710 [TBL] [Abstract][Full Text] [Related]
26. In Utero Exposure to Bisphenol a Promotes Mammary Tumor Risk in MMTV-Erbb2 Transgenic Mice Through the Induction of ER-erbB2 Crosstalk. Ma Z; Parris AB; Howard EW; Davis M; Cao X; Woods C; Yang X Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353937 [TBL] [Abstract][Full Text] [Related]
27. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953 [TBL] [Abstract][Full Text] [Related]
31. The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium. Ip MM; McGee SO; Masso-Welch PA; Ip C; Meng X; Ou L; Shoemaker SF Carcinogenesis; 2007 Jun; 28(6):1269-76. PubMed ID: 17259656 [TBL] [Abstract][Full Text] [Related]
32. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis. Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284 [TBL] [Abstract][Full Text] [Related]
33. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity. Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291 [TBL] [Abstract][Full Text] [Related]
34. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells. Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492 [TBL] [Abstract][Full Text] [Related]
35. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. Hodgson MC; Vanostran G; Alghamdi S; Poppiti RJ; Agoulnik AI; Agoulnik IU PLoS One; 2013; 8(4):e60455. PubMed ID: 23593223 [TBL] [Abstract][Full Text] [Related]
36. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer. Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764 [TBL] [Abstract][Full Text] [Related]
37. ErbB2 activation and signal transduction in normal and malignant mammary cells. Hynes NE J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):199-206. PubMed ID: 10887493 [TBL] [Abstract][Full Text] [Related]
38. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors. Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825 [TBL] [Abstract][Full Text] [Related]
39. Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation. Raven JF; Williams V; Wang S; Tremblay ML; Muller WJ; Durbin JE; Koromilas AE Cell Cycle; 2011 Mar; 10(5):794-804. PubMed ID: 21311224 [TBL] [Abstract][Full Text] [Related]
40. Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells. Ludyga N; Anastasov N; Rosemann M; Seiler J; Lohmann N; Braselmann H; Mengele K; Schmitt M; Höfler H; Aubele M Mol Cancer Res; 2013 Apr; 11(4):381-92. PubMed ID: 23364537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]